Dioli s.r.o.
- Address
- Narodna Trieda 27, Sever, 040 01 Košice, Slovakia
Dioli s.r.o. - Cardiovascular Disease Prevention Research
Dioli s.r.o. is a clinical research center dedicated to advancing cardiovascular disease prevention strategies. The facility specializes in conducting large-scale multicenter trials focused on reducing cardiovascular risk in high-risk patient populations through innovative therapeutic interventions.
- Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
- Major adverse cardiovascular events (MACE) prevention research
- Novel lipid-lowering therapy evaluation
The center's research emphasizes primary prevention approaches in patients at high cardiovascular risk, with particular expertise in evaluating treatments aimed at reducing cardiovascular death, myocardial infarction, ischemic stroke, and urgent coronary revascularization. Through rigorous randomized, double-blind, placebo-controlled study designs, Dioli s.r.o. contributes valuable evidence to help prevent cardiovascular events before they occur in vulnerable patient populations.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1AstraZeneca AB1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Novartis Pharma AG2trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 353 other sites in Slovakia
Therapeutic Area Benchmark — Slovakia
Select a therapeutic area to compare against other sites in Slovakia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Slovakia
Market Share
Country: Slovakia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Dioli s.r.o.
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Comparison of Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 with Insulin Aspart in Adults with Type 1 Diabetes | Novo Nordisk A/S | Phase III | Not Recruiting | Aug 2025 | — |
IMP list
lock Showing 1 of 8 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Dapagliflozin | 2 | Unknown | 2023-11-07 | 2025-05-06 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.